What is Atalo?
Atalo operates as a vertically integrated agriculture and biotechnology enterprise, leveraging seven generations of agricultural expertise to dominate the hemp supply chain. By focusing on the development of certified industrial hemp seeds and proprietary agronomic practices, the company has established a robust foundation in Kentucky. Their operational model encompasses the entire lifecycle of hemp production, from cultivation to state-of-the-art extraction and processing. This end-to-end control allows Atalo to provide high-quality bulk CBD ingredients and white-label solutions to a diverse client base, positioning the firm as a critical infrastructure provider in the industrial hemp market.
How much funding has Atalo raised?
Atalo has raised a total of $657K across 1 funding round:
Private Equity
$657K
Private Equity (2016): $657K, investors not publicly disclosed
Key Investors in Atalo
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Atalo?
With this major strategic investment, Atalo is well-positioned to accelerate its expansion into new market segments and enhance its processing capabilities. The company is expected to prioritize the optimization of its extraction facilities to meet the rising demand for high-purity, full-spectrum CBD products. Furthermore, the capital will likely support ongoing research and development in seed genetics, ensuring that Atalo maintains its competitive edge in agricultural efficiency. As the regulatory landscape for hemp-derived products continues to evolve, the firm's focus on transparency and quality control will be instrumental in securing long-term partnerships with enterprise-level clients seeking reliable, compliant supply chain solutions.
See full Atalo company page
